Cargando…

P1384: EFFECT OF NUTRITIONAL SUPPORT ON THE INCIDENCE OF MUCOSITIS IN AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION (AUTOHSCT) IN PATIENTS WITH HODGKIN’S LYMPHOMA. (INTERIM RESULTS)

Detalles Bibliográficos
Autores principales:	Volchenkov, S., Filatova, L., Semiglazova, T., Lyubimov, S., Zyuzgin, I., Ishmatova, I., Zverkova, A., Elkhova, S., Motalkina, M., Chudinovskikh, Y., Shalaev, S., Koviazin, A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Posters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429593/ http://dx.doi.org/10.1097/01.HS9.0000848396.26617.55

Ejemplares similares

PB2415: THE ROLE OF NUTRITIONAL SUPPORT DURING AUTOLOGOUS STEM CELL TRANSPLANTATION (AUTOHSCT) IN PATIENTS WITH HODGKIN LYMPHOMA.
por: Volchenkov, Stanislav, et al.
Publicado: (2023)

P1350: THE EFFICACY OF UPFRONT HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM CELL TRANSPLANTATION IN DECREASING RELAPSE RATE IN IV STAGE AND HIGH-INTERMEDIATE/HIGH IPI RISK GROUPS DLBCL
por: Koviazin, A., et al.
Publicado: (2022)

P1316: INCREASED EFFICACY OF INTERMEDIATE-DOSE ARAC+G-CSF COMPARED TO CY+G-CSF AND PLERIXAFOR+G-CSF AS A STEM CELL MOBILIZATION REGIMEN IN POOR MOBILIZERS WITH HEMATOLOGICAL MALIGNANCIES
por: Elkhova, Svetlana, et al.
Publicado: (2023)

The significance of upfront autologous stem cell transplantation for high‐intermediate/high‐risk stage IV diffuse large B‐cell lymphoma
por: Koviazin, Aleksei K., et al.
Publicado: (2023)

P1285: IMPROVING THE EFFECTIVENESS OF FIRST-LINE THERAPY FOR STAGE IV DIFFUSE LARGE B-CELL LYMPHOMA WITH UPFRONT AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION.
por: Koviazin, Aleksei, et al.
Publicado: (2023)

Successful Treatment of Gastric Relapse in Multiple Myeloma with Bortezomib after Autologous Hematopoietic Stem Cell Transplantation (autoHSCT)
por: Sivgin, Serdar, et al.
Publicado: (2013)

1384. Mycobacterium marinum Infection: 21 Years of Experience at a Tertiary-Care Hospital
por: Castillo Almeida, Natalia E, et al.
Publicado: (2019)

1384. Practice Variations in Pre-Hematopoietic Stem Cell Transplantation Infectious Disease Evaluation
por: Conway-Pearson, Liam S, et al.
Publicado: (2021)

Draft Genome Sequence of Purine-Degrading Gottschalkia purinilyticum (Formerly Clostridium purinilyticum) WA1 (DSM 1384)
por: Poehlein, Anja, et al.
Publicado: (2015)

1384. Conceptual Economic Model Methodology for Infant Pneumococcal Conjugate Vaccine Program and its Impact on Antimicrobial Resistance
por: Farkouh, Raymond, et al.
Publicado: (2020)

Interim FDG-PET Scan in Hodgkin's Lymphoma: Hopes and Caveats
por: André, M., et al.
Publicado: (2011)

Intramedullary nail versus locking plate for treatment of proximal humeral fractures: A meta-analysis based on 1384 individuals
por: Li, Ming, et al.
Publicado: (2018)

Interim FDG-PET/CT for therapy monitoring and prognostication in Hodgkin’s Lymphoma
por: Al-Ibraheem, Akram, et al.
Publicado: (2022)

Interobserver variability in interim PET assessment in Hodgkin lymphoma—reasons and solutions
por: Georgi, Thomas W., et al.
Publicado: (2023)

AuNP Aptasensor for Hodgkin Lymphoma Monitoring
por: Slyusarenko, Maria, et al.
Publicado: (2022)

CT-based texture analysis potentially provides prognostic information complementary to interim fdg-pet for patients with hodgkin’s and aggressive non-hodgkin’s lymphomas
por: Ganeshan, B., et al.
Publicado: (2016)

1384. RSV Monoclonal Antibody (MK-1654) Phase 1 Pharmacokinetics (PK) in Healthy Adults and Population PK Modeling to Support Pediatric Development
por: Maas, Brian, et al.
Publicado: (2018)

1384. Verbal Autopsy as a Tool to Identify Probable Cause of Death in People with Acute Febrile Illness in Zambia — January 2020-December 2022 
por: Hooker, Katie R, et al.
Publicado: (2023)

Interim thymus and activation regulated chemokine versus interim (18)F‐fluorodeoxyglucose positron‐emission tomography in classical Hodgkin lymphoma response evaluation
por: Plattel, Wouter J., et al.
Publicado: (2020)

End-of-treatment PET in early-stage Hodgkin lymphoma: valuable in addition to interim PET
por: Chohan, Karan L., et al.
Publicado: (2022)

Corrigendum to “Narita I. Estimating Growth Rate by a Single Measurement of Kidney Volume in ADPKD.” Kidney Int Rep. 2020;5:1383–1384
Publicado: (2021)

P1384: MULTI-EFFECTOR IMMUNE CELL RETARGETING USING A BISPECIFIC SINGLE-CHAIN VARIABLE FRAGMENT LIBRARY IN AGGRESSIVE B CELL LYMPHOMAS
por: Freihammer, Max, et al.
Publicado: (2023)

Hodgkin’s lymphoma: post- autologous transplantation consolidation therapy
por: Merli, Francesco, et al.
Publicado: (2020)

Interim-treatment quantitative PET parameters predict progression and death among patients with hodgkin's disease
por: Tseng, Diane, et al.
Publicado: (2012)

Autologous hematopoietic stem cell transplantation in classical Hodgkin's lymphoma
por: Cortez, Afonso José Pereira, et al.
Publicado: (2011)

Explorative analyses on the value of interim PET for prediction of response in pediatric and adolescent non-Hodgkin lymphoma patients
por: Furth, Christian, et al.
Publicado: (2013)

Predictive value of interim PET/CT visual interpretation in the prognosis of patients with aggressive non-Hodgkin’s lymphoma
por: Liao, Cheng-Cheng, et al.
Publicado: (2017)

Classical Hodgkin Lymphoma: A Joint Clinical and PET Model to Predict Poor Responders at Interim Assessment
por: Triumbari, Elizabeth Katherine Anna, et al.
Publicado: (2022)

P1077: HODGKIN LYMPHOMA IN PATIENTS WITH HIV: NATIONAL RETROSPECTIVE MULTICENTER STUDY
por: Chekalov, A., et al.
Publicado: (2022)

Pediatric Hodgkin Lymphoma: Predictive value of interim (18)F-FDG PET/CT in therapy response assessment
por: Ferrari, Cristina, et al.
Publicado: (2017)

Quantitative assessment of interim PET in Hodgkin lymphoma: An evaluation of the qPET method in adult patients in the RAPID trial
por: Georgi, Thomas W., et al.
Publicado: (2020)

Treatment of Hodgkin Lymphoma Relapsed after Autologous Stem Cell Transplantation
por: Domingo-Domènech, Eva, et al.
Publicado: (2020)

Correction: Bougma, K., et al. Iodine and Mental Development of Children 5 Years Old and Under: A Systematic Review and Meta-Analysis. Nutrients 2013, 5, 1384–1416
por: Bougma, Karim, et al.
Publicado: (2014)

Does Interim PET Scan After 2 Cycles of ABVD Predict Outcome in Hodgkin Lymphoma? Real-World Evidence
por: Seshachalam, Arun, et al.
Publicado: (2019)

Interim interleukin 6 levels correlate with progression-free survival in patients with classic Hodgkin's disease: a pilot study
por: Villanova, Pamela, et al.
Publicado: (2020)

P105: Decisional role of interim PET in relapsed/refractory classical Hodgkin Lymphoma treated with four begev cycles
por: Rusconi, Chiara, et al.
Publicado: (2022)

Quantitative magnetic resonance imaging in autologous bone marrow transplantation for Hodgkin's disease.
por: Smith, S. R., et al.
Publicado: (1989)

High dose chemotherapy and autologous bone marrow transplantation in refractory Hodgkin's disease.
por: Philip, T., et al.
Publicado: (1986)

Autologous Transplantation of Oral Mucosal Epithelial Cell Sheets Cultured on an Amniotic Membrane Substrate for Intraoral Mucosal Defects
por: Amemiya, Takeshi, et al.
Publicado: (2015)

Interim Report
por: SSC. Central Design Group. USA
Publicado: (1985)

Cannot write session to /tmp/vufind_sessions/sess_fpnbmarkh660snb9p0mar66qm3